Mike Marshall
About Mike Marshall
Managing Partner at Section 32
Mike Pellini is a Managing Partner at Section 32, a venture capital fund focused on investing at the frontiers of technology, healthcare, and life sciences. His role involves steering the fund's investment strategies and guiding portfolio companies towards growth and innovation. With his extensive experience in healthcare and technology, Pellini significantly influences Section 32’s mission to drive advancements in these critical sectors.
Former CEO and Chairman of Foundation Medicine
Mike Pellini served as CEO and Chairman of Foundation Medicine. During his tenure, he oversaw the company's operations and strategic direction, significantly contributing to its development in precision medicine. Foundation Medicine aims to transform cancer care by providing comprehensive genomic profiling solutions.
Career at Clarient and Acquisition by GE Healthcare
Before joining Foundation Medicine, Mike Pellini was President and COO of Clarient, a national leader in molecular pathology. Under his leadership, Clarient expanded its clinical and diagnostic services, which led to its acquisition by GE Healthcare in 2010. This acquisition allowed GE Healthcare to enhance their cancer diagnostics and research capabilities.
Board Memberships and Advisory Roles
Mike Pellini serves on the Board of Directors for several organizations, including Tango Therapeutics, Nusano, Vineti, Singular Genomics, Adaptive Biotechnologies, Octave Health, Thrive Earlier Detection, Sema4, Cradle Genomics, the Personalized Medicine Coalition, the GO2 Foundation, and the Mission Hospital Foundation (Providence/St. Joseph Health). Additionally, he is a member of the President’s Leadership Council at Thomas Jefferson University and Jefferson Health, and serves on the Advisory Board for Mission Hospital’s Leonard Cancer Institute.
Educational Background
Mike Pellini holds a BA from Boston College, an MBA from Drexel University, and an MD from Jefferson Medical College. His diverse educational background has provided him with a broad understanding of both the medical and business aspects of healthcare, contributing to his effectiveness as a leader in the industry.